B3-072 Viral Infection-HIV

Question 1

HIV drug resistance testing is recommended at

Answer 1

diagnosis

Question 2

[genotypic or phenotypic] testing is preferred

Answer 2

genotypic

Question 3

Should ART initiation be delayed while awaiting resistance results?

Answer 3

No, modify later

Question 4

standard genotypic drug resistance testing tests for mutations in

Answer 4

RT and PR

if integrase mutation is a concern, providers must ensure this is also tested (AIII)

Question 5

RAPID START ART

Answer 5

bictergravir/tenofovir/emtricitabine

or

dolutegravir (or boosted darunavir) + tenofovir + emtricitabine (or lamivudine)

Question 6

ART only for individuals who are HLA-B5701 negative and without HBV coinfection

Answer 6

dolutegravir/abacavir/lamivudine

Question 7

illness script: weight loss, immunodeficiency,cough, hypoxic respiratory failure, bilateral plumonary infiltrates, HIV

Answer 7

PJP

Question 8

when should PJP prophylaxis be administered?

Answer 8

CD4 <200

Question 9

when should toxoplasma gondii prophylaxis be administered?

Answer 9

CD4 <100 cells

Question 10

when should M. avium prophylaxis be administered?

Answer 10

CD4 <50 cells

Question 11

PJP is diagnosed using a _______ on a sputum sample

Answer 11

silver stain

Question 12

therapy for PJP

Answer 12

trimethoprim-sulfamethaxozole

Question 13

abacavir hypersensitivity causes

Answer 13

rash on face and chest